NHMRC Glaucoma Guidelines - ANZGIG

NHMRC GUIDELINES FOR THE SCREENING, PROGNOSIS, DIAGNOSIS, MANAGEMENT AND PREVENTION OF GLAUCOMA
Chapter 9 – Medication
Nys TRV (2008): Paternalism in Public Health Care. Public Health Ethics; 1(1):64-72.
Osterberg L, Blaschke T (2005): Adherence to Medication. The New England Journal of Medicine;
353 (5):487-497
Royal College of Ophthalmologists [RCO] (2004): Guidelines for the management of open angle
glaucoma and ocular hypertension. London: Royal College of Ophthalmologists.
Salpeter SR, Ormiston TM, Salpeter EE (2005): Cardioselective beta-blockers for chronic obstructive
pulmonary disease. Cochrane Database of Systematic Reviews; 4.
Salpeter SR, Ormiston TM, Salpeter EE, Wood-Baker R (2002): Cardioselective beta-blockers for reversible
airway disease. Cochrane Database of Systematic Reviews; 4.
Saw SM, Gazzard G, Friedman DS (2003): Interventions for angle-closure glaucoma: an evidence-based
update. Ophthalmology; 110:1869–1878.
Singapore Ministry of Health [SMOH] (2005): Clinical practice guidelines: Glaucoma. Singapore:
Ministry of Health.
South African Glaucoma Society [SAGS] (2006): Glaucoma algorithm and guidelines for glaucoma.
Hatfield: South African Glaucoma Society.
South-East Asia Glaucoma Interest Group [SEAGIG] (2003): Asia Pacific Glaucoma Guidelines.
Sydney: South-East Asia Glaucoma Interest Group.
South-East Asia Glaucoma Interest Group [SEAGIG] (2007): Asia Pacific Glaucoma Guidelines
(2nd edn.) available at http://www.seagig.org/apgg2.php
Stamper RL, Lieberman M, Drake MV (1999): Becker-Shaffer’s diagnosis and therapy of the
glaucomas (7th edn). St Louis: Mosby Inc pp422.
Tripathi RC, Tripathi BJ, Haggerty C (2003): Drug-Induced Glaucomas Mechanism and Management.
Drug Safety; 26(11): 749-767.
Tsai JC (2006): Medication adherence in glaucoma: approaches for optimizing patient compliance.
Current Opinion in Ophthalmology; 17(2):190-195.
National Health and Medical Research Council 137